Many of our clients have published their research and acknowledged TransPharm’s role in their work. Check out a few of the manuscripts and poster presentations based on studies we’ve completed.
Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile
Broad Institute of MIT and Harvard
Zolav®: A New Antibiotic for the Treatment of Acne
Boulos and Cooper Pharmaceuticals
Subcutaneous (SC) Injection of CD101, a Novel Echinocandin: Efficacious, Well-Tolerated, and Sustained Drug Exposures
Efficacy and Impact to the Microbiome of Novel Specifically-Targeted Antimicrobial Peptides against C. difficile Infection
SASP: Efficacy of Pa SASPject against Pseudomonas aeruginosa ATCC 27853 in a Mouse Lung Model